Showing results (81-90 of 166) with videos related to
Sort By:
Pageof 17
Clinical Lymphoma, Myeloma & Leukemia|June 29, 2017
Final Results of a Phase 1 Study of Vorinostat, Pegylated Liposomal Doxorubicin, and Bortezomib in Relapsed or Refractory Multiple MyelomaPeter M Voorhees, Cristina Gasparetto, Dominic T Moore, et al.Medical Care|January 25, 2003
Forecasting the nursing home populationDarius Lakdawalla, Dana P Goldman, Jay Bhattacharya, et al.Gynecologic Oncology|August 1, 1994
Salvage therapy for recurrent and refractory ovarian cancer with high-dose chemotherapy and autologous bone marrow support: a Gynecologic Oncology Group pilot studyE R Broun, J L Belinson, J S Berek, et al.Journal of Behavioral Medicine|March 1, 1980
Prevention of cigarette smoking in seventh grade studentsP D Hurd, C A Johnson, T Pechacek, et al.Transfusion|July 1, 1991
Adverse reactions in patients transfused with cryopreserved marrowD F Stroncek, S K Fautsch, L C Lasky, et al.The American Journal of Hospice & Palliative Care|October 22, 2013
Hematopoietic stem cell transplant candidate and designated proxy distress levels prior to hematopoietic stem cell transplantationKatharine E Duckworth, Allison M Forti, Gregory B Russell, et al.Blood|June 1, 1982
Protein A adsorption of acute myelogenous leukemia serum induces in vitro blast lysisW J Miller, R F Branda, D D Hurd, et al.Bone Marrow Transplantation|March 7, 2003
Fatal EBV-related post-transplant lymphoproliferative disorder (LPD) after matched related donor nonmyeloablative peripheral blood progenitor cell transplantK W Zamkoff, S Bergman, M W Beaty, et al.Lancet (London, England)|September 18, 1982
Successful allogeneic bone-marrow transplantation for patients in the accelerated phase of chronic granulocytic leukaemiaP B McGlave, D C Arthur, T H Kim, et al.Annals of Internal Medicine|January 1, 1988
Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphomaE G Levine, D C Arthur, G Frizzera, et al.Pageof 17